Platform products for self-injection

Platform products for self-injection

Product Gallery

Information

Ypsomed’s platform portfolio offers advanced self-injection devices, including reusable and prefilled pens, autoinjectors, wearable injectors, and digital health solutions. Each platform is engineered in Switzerland for fast, efficient customisation, significantly reducing time to market and minimising development risks by using pre-developed, proven technologies. The adaptable manufacturing processes support both small-scale clinical trials and high-volume commercial production, ensuring scalability as needed. This flexibility enables an efficient transition from development to market, providing reliable, safe drug delivery solutions at every stage.
Country
Switzerland
Product Type
Self-injection devices
Application Areas
For biologics and small molecules. For a broad range of therapies, such as hormone therapies (hGH, FSH), autoimmune diseases, diabetes, obesity, rare diseases, oncology
Key Features
Designed and developed in Switzerland. Fast and easy customisation. Patented products minimise project risks. Proven safety through human factor studies. Advanced large-scale automation. Compliant with international regulatory standards.
Website
https://yds.ypsomed.com/en/products.html
Ypsomed AGYpsomed is the leading independent developer and manufacturer of innovative and user-friendly self-injection systems. The customisable product platforms cover autoinjectors for prefilled syringes in 1 mL and 2.25 mL formats, prefilled patch injectors for fill volumes up to 10 mL, disposable pens for 3 mL and 1.5 mL cartridges, reusable pens that include automated injection mechanisms and easy-to-use injection devices for drugs in dual-chamber cartridges. Unique click-on pen needles and infusion sets complement the broad self-injection systems product portfolio.

Log in

See all the content and easy-to-use features by logging in or registering!